Private Capital Group’s Sana Biotechnology SANA Stock Holding History

Private Capital Group’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Buy	+240	New	+$1.53K	﹤0.01%	1579

Other funds holding SANA

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Capital Group's SANA Position: Q2 2022 in Review

Private Capital Group opened a new position in Sana Biotechnology (SANA) in Q2 2022: 240 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings.

116 funds tracked by Wall St. Rank hold SANA as of Q2 2022.

Private Capital Group held 240 shares of Sana Biotechnology worth $2K as of Q2 2022.
Sana Biotechnology was a new Private Capital Group position in Q2 2022.
Sana Biotechnology made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1579 holding.
116 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.